Accordingly, our observation made in SR-BI−/− mice studies also supported that the identification of significant proteins in dysfunctional HDL using SR-BI−/− mice as a model, might provide a powerful clue for exploring the biomarkers in clinical diagnosis and therapeutics of dysfunctional HDL-related metabolic diseases. This evidence concerns the gene SCARB1 and metabolic disease.